IFI44 and non-small cell lung carcinoma: LINC01116 also modulated gefitinib resistance in non-small cell lung cancer (NSCLC) cells by regulating interferon-induced protein (IFI)44 expression, suggesting a potential mechanism for drug resistance in NSCLC [32].